Dr. Peter Rinck, PhD[email protected]Clinical NewsGlobal congresses face deeply uncertain futureECR 2020 Online begins on 15 July, but it represents a huge challenge to recreate "the Vienna experience" virtually, writes the Maverinck. He admires the organizers' speedy and skillful efforts to adjust to the new situation, but success is not guaranteed.July 6, 2020Artificial IntelligenceIs COVID-19 nature's fight back against human hubris?The main lesson from the pandemic that tortures all of us is that nature consistently fights back against the excessive pride and arrogance of humans, the Maverinck writes. We've made progress in medicine and technology, but we've lost compassion and mercy, he believes.May 11, 2020Artificial IntelligenceCloud computing isn't the answer to all our prayersCloud computing carries an inherent, incalculable risk, the Maverinck writes in a new column. Also, he fears future generations will suffer from a kind of digital amnesia because old data formats will no longer be readable.April 12, 2020Clinical NewsMRI safety first? Or last?The recent spate of MRI accidents in Sweden is due to thoughtlessness, and the damage seems self-inflicted, writes the Maverinck. MR machines are not toys, and operating them requires concentration and knowing and not forgetting the rules.January 8, 2020Clinical NewsMaverinck responds to Karolinska radiology chief's rebuttalThe people to blame for the controversial construction of the New Karolinska have gone into hiding and rely on smoke-screen tactics, while those now trying to run the dysfunctional hospital are faced with operational problems beyond belief and major financial restrictions, writes the Maverinck.August 19, 2019Clinical NewsWhat's gone wrong at the Karolinska?Regular articles continue to appear in Swedish newspapers about the huge building and corruption scandal at the New Karolinska Hospital. Many doctors are leaving, patients are suffering, and some observers think the scandal is so large that it can never be thoroughly investigated. The Maverinck tells the story.August 6, 2019Artificial IntelligenceData validation promises to make or break AIIn June, Ranga Yogeshwar, a physicist and science journalist from Luxembourg, made some competent and critical comments about artificial intelligence (AI) and expressed his concerns about data validation. The Maverinck tells the story in his latest column.July 23, 2019Clinical NewsWhere are we now on gadolinium uptake in the brain?Researchers are striving to understand how and why gadolinium is retained. Studies focus on MRI contrast agents' in vivo stability, how gadolinium crosses biological barriers, the chemical form of the retained compounds, and the relationship between compounds and local image hyperintensities, writes the Maverinck.July 2, 2019MRIWhat lies ahead for MRI contrast agents?It will be extremely difficult to develop a new MR contrast agent that fulfills unsatisfied clinical needs and has a large enough range of applications to justify the development costs, writes the Maverinck. We present the second part of his column about MRI's future.May 27, 2019Clinical NewsMR imaging: Quo vadis?Surprisingly little has changed since MRI became a clinical tool in the 1980s, writes the Maverinck. In the first of a two-part column, he presents a personal view of the main ongoing controversies and unresolved issues in the modality, including magnetic field strength and flawed research.May 21, 2019Previous PagePage 2 of 10Next PageTop StoriesUltrasoundSamsung Medison to acquire SonioSonio will remain an independent company headquartered in France, according to Samsung Medison.Womens ImagingHologic brings Brevera 7-gauge breast biopsy needle to EuropeNuclear MedicineITM appoints chief medical officerIndustry NewsSiemens reports revenue, profit gains in Q2Sponsor ContentJourney to the Cloud: A Snapshot of Market Progress - 22 May @ 7pm CET
